galenica ag-reg (GALN:SIX Swiss Ex)
galenica ag-reg (GALN) Snapshot
|
Open
SFr.622.00
|
Previous Close
SFr.625.00
|
|
|
Day High
SFr.630.00
|
Day Low
SFr.618.00
|
|
|
52 Week High
05/22/13 - SFr.635.00
|
52 Week Low
11/16/12 - SFr.479.25
|
|
|
Market Cap
4.1B
|
Average Volume 10 Days
19.4K
|
|
|
EPS TTM
SFr.39.17
|
Shares Outstanding
6.5M
|
|
|
EX-Date
05/6/13
|
P/E TM
15.9x
|
|
|
Dividend
SFr.11.00
|
Dividend Yield
1.76%
|
Related News
galenica ag-reg (GALN) Related Businessweek News
No Related Businessweek News Foundgalenica ag-reg (GALN) Details
Galenica Ltd. develops, manufactures, and markets pharmaceutical products primarily in Switzerland, Europe, and the United States. Its Pharma segment offers iron replacement products, such as Ferinject, Venofer, and Maltofer; immuno-stimulant products comprising Broncho-Vaxom and Uro-Vaxom; infectious diseases/OTX products, over-the-counter products, and herbal remedies; and synthetic and biotech drugs for the therapeutic area of immunology and infectious diseases. This segment also develops and markets products for patients suffering from chronic kidney disease; develops and markets CellCept for various applications involving autoimmune diseases; and markets products manufactured by third parties. The company’s Logistics segment offers prewholesale logistics services, including storage and distribution of products, and debt collection services to pharmaceutical and healthcare companies; supplies healthcare products to pharmacies, physicians, drug stores, and hospitals; and handles and coordinates the purchase, sale, warehousing, and distribution of products for third parties. Galenica Ltd.’s Retail segment operates 467 pharmacies, including 300 own pharmacies and 167 partner pharmacies under the Amavita and Sun Store brands in Switzerland. This segment also operates a chain of own sales points in partnership under the Coop Vitality brand; MediService specialty pharmacy that offers medication for in-home therapies; and 153 Winconcept partner pharmacies. The company’s HealthCare Information segment provides master data systems for the healthcare market; and publishes printed and electronic technical information on pharmaceutical products. This segment also maintains databases; develops and markets management solutions under the Triamun brand; TriaPharm total management software solution for pharmacies; TriaMed software for physicians; and TriaOne non-sector specific ERP solution for retail. Galenica Ltd. was founded in 1927 and is headquartered in Berne, Switzerland.
galenica ag-reg (GALN) Top Compensated Officers
galenica ag-reg (GALN) Key Developments
Galenica Ltd. Presents at 16th dbAccess German, Swiss and Austrian Conference, May-14-2013 through May-15-2013. Venue: Hilton Hotel, Frankfurt/Main, Germany. Presentation Date & Speakers: May-14-2013, Fritz Hirsbrunner, Head of Investor Relations, Director and Member of Financial Committee.
Galenica Ltd. reported consolidated earnings results for the year 2012. For the period, the company reported EBIT of CHF 349.6 million against CHF 327.1 million a year ago. EBITDA was CHF 425.7 million against CHF 399.4 million a year ago. Net profit attributable to shareholders of company was CHF 253.5 million against CHF 223.1 million a year ago. Net sales increased by 3.4% to CHF 3,294.3 million. The company invested CHF 138.9 million (+6.5%) in research & development in the year under review, in addition to its expenditure on the formation of a network of affiliates in Europe. The company devoted about CHF 250 million to measures aimed at preparing for the future and invested altogether CHF 53.5 million (-11.4%) in tangible and intangible assets. Net debt fell by 19.9% to CHF 567.5 million, with gearing again declining significantly from 59% to 41%. The company announced that at the annual general meeting to be held on May 5, 2013, shareholders will consider a dividend increase of 22% to CHF 11.00 per registered share. The company has set itself the target of achieving at least the same level of profit in 2013 as in the previous year.
Karin Priarollo is leaving Galenica Ltd. by mutual agreement. She has resigned with immediate effect from her role as Head of Human Resources of the company and member of the Corporate Executive Committee. The new Head of Human Resources of the Group will be Jorg Kneubuhler, CFO and member of the Corporate Executive Committee.
| Recently Viewed | |||
| GALN:SW | SFr.623.50 CHF | -1.50 |  |
| Company | Last | Change |
| Cardinal Health Inc | $46.97 USD | -0.20 |
| Celesio AG | €15.94 EUR | -0.04 |
| McKesson Corp | $117.04 USD | -0.245 |
| United Drug PLC | 326.80 GBp | +1.80 |
| Walgreen Co | $50.31 USD | -0.09 |
| View Industry Companies | ||
Industry Analysis
GALN
Industry Average
| Valuation | GALN | Industry Range |
| Price/Earnings | 15.1x |
|
| Price/Sales | 1.1x |
|
| Price/Book | 2.8x |
|
| Price/Cash Flow | 11.7x |
|
| TEV/Sales | 0.7x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact GALENICA AG-REG, please visit www.galenica.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
